Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Comparison between preoperative versus intraoperative injection of technetium-99 m neomannosyl human serum albumin for sentinel lymph node identification in early stage lung cancer.
Kim HK, Kim S, Sung HK, Lee YS, Jeong JM, Choi YH.
Ann Surg Oncol. 2012 Apr;19(4):1343-9. Epub 2011 Dec 6.
Related citations
Data collection helps to close gap in treatment of lung cancer patients.
Wise J.
BMJ. 2011 Dec 6;343:d7941. doi: 10.1136/bmj.d7941. No abstract available.
A single-nucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
Mak RH, Alexander BM, Asomaning K, Heist RS, Liu CY, Su L, Zhai R, Ancukiewicz M, Napolitano B, Niemierko A, Willers H, Choi NC, Christiani DC.
Cancer. 2011 Dec 5. doi: 10.1002/cncr.26667. [Epub ahead of print]
Pushing forward into the darkness, leaping, and landing securely: prognostication and adjuvant chemotherapy for lung cancer.
Detterbeck FC.
Chest. 2011 Dec;140(6):1398-400. No abstract available.
Prognostic immune markers in non-small cell lung cancer--letter.
Pandey JP.
Clin Cancer Res. 2011 Dec 15;17(24):7835; author reply 7836. Epub 2011 Dec 6. No abstract available.
Error occurred: cannot get document summary
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancer.
Carter DL, Garfield D, Hathorn J, Mundis R, Boehm KA, Ilegbodu D, Asmar L, Reynolds C.
Clin Lung Cancer. 2012 May;13(3):205-13. Epub 2011 Dec 3.
Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
Hanagiri T, Takenaka M, Oka S, Shigematsu Y, Nagata Y, Shimokawa H, Uramoto H, Tanaka F.
Clin Lung Cancer. 2012 May;13(3):220-4. Epub 2011 Dec 3.
Expression and clinical significance of ezrin in non--small-cell lung cancer.
Zhang XQ, Chen GP, Wu T, Yan JP, Zhou JY.
Clin Lung Cancer. 2012 May;13(3):196-204. Epub 2011 Dec 3.
Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non--small-cell lung cancer.
Skoura E, Datseris IE, Platis I, Oikonomopoulos G, Syrigos KN.
Clin Lung Cancer. 2012 May;13(3):181-7. Epub 2011 Dec 1.
Tripchlorolide induces cell death in lung cancer cells by autophagy.
Chen L, Liu Q, Huang Z, Wu F, Li Z, Chen X, Lin T.
Int J Oncol. 2012 Apr;40(4):1066-70. doi: 10.3892/ijo.2011.1278. Epub 2011 Dec 1.
A Phase I Study of Amrubicin and Fixed Dose of Irinotecan (CPT-11) in Relapsed Small Cell Lung Cancer: Japan Multinational Trial Organization LC0303.
Kawahara M, Kubo A, Komuta K, Fujita Y, Sasaki Y, Fukushima M, Daimon T, Furuse K, Mishima M, Mio T.
J Thorac Oncol. 2011 Dec 1. [Epub ahead of print]
FATS expression is associated with cisplatin sensitivity in non small cell lung cancer.
Tian Y, Zhang J, Yan S, Qiu L, Li Z.
Lung Cancer. 2012 Jun;76(3):416-22. Epub 2011 Dec 2.
Activation of PPARĪ³ in myeloid cells promotes lung cancer progression and metastasis.
Li H, Sorenson AL, Poczobutt J, Amin J, Joyal T, Sullivan T, Crossno JT Jr, Weiser-Evans MC, Nemenoff RA.
PLoS One. 2011;6(12):e28133. Epub 2011 Dec 1.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on